APA (7th ed.) Citation

Tremblay, G., Daniele, P., Breeze, J., Li, L., Shah, J., Shacham, S., . . . Sundar, J. (2021). Quality of life analyses in patients with multiple myeloma: Results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study. BMC cancer, 21, . https://doi.org/10.1186/s12885-021-08453-9

Chicago Style (17th ed.) Citation

Tremblay, Gabriel, et al. "Quality of Life Analyses in Patients with Multiple Myeloma: Results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) Phase 2b Study." BMC Cancer 21 (2021). https://doi.org/10.1186/s12885-021-08453-9.

MLA (9th ed.) Citation

Tremblay, Gabriel, et al. "Quality of Life Analyses in Patients with Multiple Myeloma: Results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) Phase 2b Study." BMC Cancer, vol. 21, 2021, https://doi.org/10.1186/s12885-021-08453-9.